Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1996-03-01
1998-11-24
McKelvey, Terry A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530350, A61K 3818, C07K 14515
Patent
active
058406930
ABSTRACT:
VEGF-B polypeptides from the PDGF family of growth factors having the property of promoting mitosis and proliferation of vascular endothelial cells, DNA sequences encoding these polypeptides, pharmaceutical compositions containing them and antibodies which react with them. The VEGF-B polypeptides are useful in stimulating angiogenesis as well as in diagnostic applications.
REFERENCES:
patent: 5607918 (1997-03-01), Eriksson et al.
Olofsson et al., "Vascular Endothelial Growth Factor B, a Novel Growth Factor Endothelial Cells", Proc. Natl. Acad. Sci. USA, vol. 93, pp. 2576-2581 (1996).
Orlandini et al., "Identification of a c-fos-Induced Gene That is Related to the Platelet-Derived Growth Factor/Vascular Endothelial Growth Factor Family", Proc. Natl. Acad. Sci. USA, vol. 93, pp. 11675-11680 (1996).
Ngo et al, The Protein Folding Problem and Tertiary Structure Prediction, 1994, Mertz et al (eds), Birkhauser, Boston, MA, pp. 433 and 492-495.
Alitalo Kari
Eriksson Ulf
Olofsson Birgitta
Pajusola Katri
Helsinki University Licensing Ltd. Oy
Ludwig Institute for Cancer Research
McKelvey Terry A.
LandOfFree
Vascular endothelial growth factor-B does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vascular endothelial growth factor-B, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vascular endothelial growth factor-B will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1702223